The cytotoxicity of eosinophil cationic protein/ribonuclease 3 on eukaryotic cell lines takes place through its aggregation on the cell membrane

• DOI: 10.1007/s00018-007-7499-7
• Publication Date: 2007-12-17T05:17:21Z
• Authors: S. Navarro; J. Aleu; M. Jiménez; E. Boix; C. M. Cuchillo; M. V. Nogués
• Keywords: 0303 health sciences; Cell Membrane Permeability; Microscopy, Confocal; Cell Death; Cell Cycle; Cell Membrane; Eosinophil Cationic Protein; Lipid Bilayers; Intracellular Space; HL-60 Cells; Phosphatidylserines; Caspase Inhibitors; Cell Line; Protein Transport; 03 medical and health sciences; Eukaryotic Cells; Humans; RNA; Calcium; Protein Structure, Quaternary; Reactive Oxygen Species; HeLa Cells

Human eosinophil cationic protein (ECP)/ ribonuclease 3 (RNase 3) is a protein secreted from the secondary granules of activated eosinophils. Specific properties of ECP contribute to its cytotoxic activities associated with defense mechanisms. In this work the ECP cytotoxic activity on eukaryotic cell lines is analyzed. The ECP effects begin with its binding and aggregation to the cell surface, altering the cell membrane permeability and modifying the cell ionic equilibrium. No internalization of the protein is observed. These signals induce cell-specific morphological and biochemical changes such as chromatin condensation, reversion of membrane asymmetry, reactive oxygen species production and activation of caspase-3-like activity and, eventually, cell death. However, the ribonuclease activity component of ECP is not involved in this process as no RNA degradation is observed. In summary, the cytotoxic effect of ECP is attained through a mechanism different from that of other cytotoxic RNases and may be related with the ECP accumulation associated with the inflammatory processes, in which eosinophils are present.